Avian flu viruses which are transmissible between humans could evolve in nature

23 June, 2012

See on Scoop.itVirology News

It might be possible for human-to-human airborne transmissible avian H5N1 influenza viruses to evolve in nature, new research has found.

The findings, from research led by Professor Derek Smith and Dr Colin Russell at the University of Cambridge, were published June 22 in the journal Science.
Currently, avian H5N1 influenza, also known as bird flu, can be transmitted from birds to humans, but not (or only very rarely) from human to human. However, two recent papers by Herfst, Fouchier and colleagues in Science and Imai, Kawaoka and colleagues in Nature reveal that potentially with as few as five mutations (amino acid substitutions), or four mutations plus reassortment, avian H5N1 can become airborne transmissible between mammals, and thus potentially among humans. However, until now, it was not known whether these mutations might evolve in nature.
The Cambridge researchers first analysed all of the surveillance data available on avian H5N1 influenza viruses from the last 15 years, focusing on birds and humans. They discovered that two of the five mutations seen in the experimental viruses (from the Fouchier and Kawaoka labs) had occurred in numerous existing avian flu strains. Additionally, they found that a number of the viruses had both of the mutations.
Colin Russell, Royal Society University Research Fellow at the University of Cambridge, said: “Viruses that have two of these mutations are already common in birds, meaning that there are viruses that might have to acquire only three additional mutations in a human to become airborne transmissible. The next key question is ‘is three a lot, or a little?’ “

 

So: was it a good idea to publish those two papers on mutating H5N1 viruses, or not?  Given that as I and many other more famous people pointed out, if you don’t know what makes the viruses mammal-to-mammal transmissible, you don’t know what to look for – and now we do, and look what they found.  This story will run, and run, and run – so we really, really should include an H5 consensus HA in seasonal flu vaccines!!

See on www.sciencedaily.com

Non-canonical translation in RNA viruses

23 June, 2012

See on Scoop.itVirology News

“Viral protein synthesis is completely dependent upon the translational machinery of the host cell. However, many RNA virus transcripts have marked structural differences from cellular mRNAs that preclude canonical translation initiation, such as the absence of a 5′ cap structure or the presence of highly structured 5′UTRs containing replication and/or packaging signals. Furthermore, whilst the great majority of cellular mRNAs are apparently monocistronic, RNA viruses must often express multiple proteins from their mRNAs. In addition, RNA viruses have very compact genomes and are under intense selective pressure to optimize usage of the available sequence space. Together, these features have driven the evolution of a plethora of non-canonical translational mechanisms in RNA viruses that help them to meet these challenges. Here, we review the mechanisms utilized by RNA viruses of eukaryotes, focusing on internal ribosome entry, leaky scanning, non-AUG initiation, ribosome shunting, reinitiation, ribosomal frameshifting and stop-codon readthrough. The review will highlight recently discovered examples of unusual translational strategies, besides revisiting some classical cases.”

 

Great article for anyone interested in how RNA viruses subvert cellular processes.

See on vir.sgmjournals.org

Condoms not effective against HPV or herpes

23 June, 2012

See on Scoop.itVirology News

“Viral STDs make up the modern “4-H club.” Herpes simplex virus (HSV), human papilloma virus (HPV), hepatitis (B and C), and HIV are the most common STDs, causing pain, cancer, liver disease and AIDS, respectively.

Condoms significantly decrease transmission rates of the most life-threatening viruses, HIV and hep B and C.

Unfortunately, condoms do not do an adequate job of protecting against human papilloma or herpes simplex virus infections. Women diagnosed with HPV are often mystified and frustrated, having been “super careful,” or picky, in choosing intimate partners and faithfully using condoms for all intercourse.

But UCSF researchers have shown these viruses to be present on genital skin with no symptoms that might prompt diagnosis and treatment. That means HPV and HSV can be deposited on the condom’s outer surface from viral particles living on the scrotum, penile shaft not covered by the condom or vaginal/vulvar tissues.”

 

Interesting – because it’s been known a while that condoms are less effective in preventing spread of HPV than for bacterial STDs and HIV, and now we know why.  The only things that can really prevent the transmission of these agents, in the absence of abstinence, is vaccination.

See on www.sfgate.com

[dsRNA] Treatment for deadly bee virus promising

23 June, 2012

See on Scoop.itVirology News

“There’s buzz about a new treatment that could save bee populations from a deadly virus.
Researchers at the University of Manitoba have found a way to suppress the deformed-wing virus (DWV), which has had catastrophic effects on bee colonies worldwide, causing many to have crumpled or deformed wings.
Entomology PhD student Suresh Desai fed his bees double-stranded RNA, a treatment that prevented the virus from expressing itself in the host.
“It gives us a little bit of hope that we can manage this virus, because there is no control mechanism right now,” he said.
The study, published online on Insect Molecular Biology on June 12, showed bees fed the double-stranded RNA in a syrup and then inoculated with the virus had a much better survival rate than those who weren’t. RNA is much like DNA, but is in a single strand. It carries the genetic material of some viruses, including DWV. RNA is taken from the DWV and then converted into a double strand. When introduced in the bee, it suppresses the viral RNA.”

 

I find it fascinating that the dsRNA that we as plant virologists grew to know and love in the 1980s – because it’s easier to isolate from plants than ssRNA, and far more stable – has newly become so much more useful as an anti-viral therapeutic.  And you can isolate a tonne of dsRNA from virus-infected insects, too, so it’s also interesting why exogenous material should be effective.

See on www.winnipegfreepress.com

The subgenomic promoter of brome mosaic virus folds into a stem–loop structure capped by a pseudo-triloop that is structurally similar to the triloop of the genomic promoter

23 June, 2012

See on Scoop.itVirology News

In brome mosaic virus, both the replication of the genomic (+)-RNA strands and the transcription of the subgenomic RNA are carried out by the viral replicase. The production of (−)-RNA strands is dependent on the formation of an AUA triloop in the stem–loop C (SLC) hairpin in the 3′-untranslated region of the (+)-RNA strands. Two alternate hypotheses have been put forward for the mechanism of subgenomic RNA transcription. One posits that transcription commences by recognition of at least four key nucleotides in the subgenomic promoter by the replicase. The other posits that subgenomic transcription starts by binding of the replicase to a hairpin formed by the subgenomic promoter that resembles the minus strand promoter hairpin SLC. In this study, we have determined the three-dimensional structure of the subgenomic promoter hairpin using NMR spectroscopy. The data show that the hairpin is stable at 30°C and that it forms a pseudo-triloop structure with a transloop base pair and a nucleotide completely excluded from the helix. The transloop base pair is capped by an AUA triloop that possesses an extremely well packed structure very similar to that of the AUA triloop of SLC, including the formation of a so-called clamped-adenine motif. The similarities of the NMR structures of the hairpins required for genomic RNA and subgenomic RNA synthesis show that the replicase recognizes structure rather than sequence-specific motifs in both promoters.

See on rnajournal.cshlp.org

Trade Secrets: Are Green Vaccines Appropriate for Africa? : Trade Secrets

21 June, 2012

See on Scoop.itVirology News

I have mentioned several times here, and elsewhere, that my lab works on expressing vaccine-relevant viral proteins in plants – and that I think this is a highly appropriate technology for the purpose.  Read more…

See on blogs.nature.com

Dengue vaccine results from Thailand trial expected by September | The Jakarta Post

16 June, 2012

See on Scoop.itVirology News

The efficacy of the first dengue fever vaccine is expected to be known by September when results of tests on thousands of Thai children will be …

See on www.thejakartapost.com

GM Crops Offer Natural Pest Control | The Scientist

14 June, 2012

See on Scoop.itVirology News

“They found that across all sites as insecticide spraying declined, predatory arthropod populations rose, bringing down populations of aphids, insects that consume and damage crops by carrying viruses . In addition, the team also studied experimental Bt cotton plots, and found that where predator populations were high in the Bt cotton, they were correspondingly high in surrounding peanut and soybean plots, suggesting the benefits of increased predators spilled over to neighboring crops.”

 

In.  Your.  FACES!!  Loony.  Greenies.  Actual proven BENEFITS!!  From GM!!  From a long term, HUGE experiment!!  I’ve been waiting a while for this.

See on the-scientist.com

Canadian researchers thwart Ebola virus

14 June, 2012

See on Scoop.itVirology News

Cure has the longest treatment window so far resulting in full recovery – a full day…The treatment, in which injections of protein-grabbing antibodies stop a virus from replicating, has the longest treatment window so far resulting in full recovery – a full day. There’s just one catch: It can take up to two weeks for symptoms of the disease to appear.

In an article published Wednesday in Science and Translational Medicine, Gary Kobinger and several others outline the cocktail of antibodies they used to treat macaque monkeys infected with the most lethal strain of Ebola virus. All the macaques treated 24 hours after infection recovered, as did half of those treated after 48 hours.

I must learn how to do science via press release – looks like you get much more interest that way….
See on www.theglobeandmail.com

Single science council proposed for South Africa

12 June, 2012

See on Scoop.itVirology News

“A committee has advised South Africa’s government to set up a national council to steer the country’s research agenda and make recommendations on all major funding allocations to science and innovation.

The 15 to 20 member council would be chaired by the country’s deputy president and the science minister would be deputy chair, to ensure legitimacy across all government departments.

The council would include other ministers as well as representatives from academia and industry, says the committee’s report, published for public consultation on 6 May by the Department of Science and Technology.”

While a good idea in principle, this could work out just like SA’s last effort at consolidating funding bodies: the creation of the Technology and Innovation Agency resulted in the abrupt cessation of funding from the bodies it replaced, with only a trickle starting to become available now.

See on www.research-africa.net